An in vitro study to determine the minimum inhibitory concentration of Melaleuca alternifolia against the dermatophyte Trichophyton rubrum

Foot

Volumn 14, Issue 2, 2004, Pages 86-91

  Benger, Steven ^a   Townsend, Paul ^b   Ashford, Robert L ^a   Lambert, Peter ^c  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b Aston University ^*  (Australia)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

Concentration; Melaleuca alternifolia; Minimum inhibitory; Trichophyton rubrum

Indexed keywords

TEA TREE OIL;

ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATOPHYTE; DRUG POTENCY; FUNGUS GROWTH; IN VITRO STUDY; MEDICAL LITERATURE; MELALEUCA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRICHOPHYTON RUBRUM;

EID: 2342417556     PISSN: 09582592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foot.2003.11.002     Document Type: Article

References (31)

1. Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clin Microb Rev 1998; 11(3):415-29.
2. Gupta AK, Scher RK, De Doncker P. Current management of onychomycosis. An overview. Dermatol Clin 1997;15(1):121-35.
3. Gupta AK, Shear NH. The new oral antifungal agents for onychomycosis of the toenails. J Eur Acad Dermatol Venereol 1999; 13(1):1-13.
4. Jaffe R. Onychomycosis: recognition, diagnosis and management. Arch Fam Med 1998;7(6):587-92.
5. Odom RB. New therapies for onychomycosis. J Am Acad Dermatol 1996;35(3 Pt 2):26-30 (online). Available from: Pubmed. http://www.ncbi.nlm.nih.gov.
6. Pierard GE, Arrese-Estrada J, Pierard-Franchimont C. Treatment of onychomycosis, traditional approaches. J Am Acad Dermatol 1993;29(1):841-5.
7. Roberts DT. Onychomycosis: current treatment and future challenges. Department of Dermatology, Southern General Hospital, Glasgow; 1999. Available from: d.t.robertsγlinmed.gla.ac.uk.
8. Bradley MC, Leidich S, Isham N, Elewski BE, Ghannoum MA. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Department of Dermatology, Case Western Reserve University, University Hospitals of Cleveland, OH, USA; 1999.
9. Buck DS, Nidorf D, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Family Practice 1994;38(6):601-5.
10. Concha JM, Moore LS, Holloway WJ. Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms. J Am Pod Med Assoc 1998;88(10):489-92.
11. Williams LR. Clonal production of tea tree oil high in terpinen-4-ol for use in formulations for the treatment of thrush. Complement Ther Nurs Midwifery 1998;4(5):133-6.
12. Altman PM. Australian tea tree oil. Aust J Pharm 1998;69:276-8.
13. Bassett IB, Pannowitz DL, Barnetson RStC. A comparative study of tea tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990;153:455-8.
14. Garg AP, Smith SN, Pugh JF. An improved technique to incorporate oils and fats into culture media. Trans Br Mycol Soc 1994;82(2): 356-8.
15. Beylier MF. Bacteriostatic activity of some Australian essential oils. Perfumer Flavorist 1997;4(2):23-5.
16. Walsh L, Longstaff J. The antimicrobial effects of an essential oil on selected oral pathogens. Periodontology 1987;8:11-5.
17. Hammer KA, Carson CF, Riley TV. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 1996;24(3):186-9.
18. Remmal A, Bouchiki T, Rhayour K, Ettayebi M. Improved method for the determination of antimicrobial activity of essential oils in agar medium. J Essent Oil Res 1993;5:179-84.
19. Kishore N, Mishra AK, Chansouria JPN. Fungitoxicity of essential oils against dermatophytes. Mycoses 1993;36:211-5.
20. Del Beccaro MA. Melaleuca oil poisoning in a 17-month-old. Vet Hum Toxicol 1995;37(6)557-8 (online). Available from: Pubmed http://www.ncbi.nlm.nih.gov.
21. Goodwin G, Hardiman S. Tea tree oil as a therapeutic agent. Podiatry Now 2000;3(6):234-7.
22. Jacobs MR, Hornfeldt CS. Melaleuca oil poisoning (online). 1994. Available from: Pubmed http://www.ncbi.nlm.nih.gov.
23. Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol 1994;30(3):423-7 (online). Available from: Pubmed. http://www.ncbi.nlm.nih.gov.
24. Rubbel DM, Freeman S, Southwell IA. Tea tree oil: what is the offending agent? Report of three cases of tea tree oil allergy and review of the literature. Australas J Dermatol 1998;39(4): 244-7 (online). Available from: Pubmed. http://www.ncbi.nlm.nih.gov.
25. Selvaag E, Eriksen B, Thune P. Contact allergy due to tea tree oil and cross-sensitisation to colophony. Contact Dermatitis 1994;31:124-5.
26. Van Der Valk PG, De Groot AC, Bruynzeel DP, Coenraads PJ, Weijland JW. Allergic contact eczema due to tea tree oil. Nederlands Tijdschrift voor Geneeskunde 1994;138(16):823-5 (online). Available from: Pubmed http://www.ncbi.nlm.nih.gov.
27. Weiss RR, James WD. Allergic contact dermatitis from aromatherapy. Am J Contact Dermatitis 1997;8(4):250-1.
28. Dahl MV, Grando SA. Chronic dermatophytosis: what is special about Trichophyton rubrum? Adv Dermatol 1994;9:97-109.
29. Venugopal PV, Venugopal TV. Antidermatophytic activity of garlic (Allium sativum) in vitro. Int J Dermatol 1995;34(4):278-9.
30. Garg AP, Smith SN, Pugh GJF. Inhibition of growth of keratinophilic fungi by oils and fatty acids. Trans Br Mycol Soc 1985;85(2):367-70.
31. Lis-Balchin M, Deans S, Hart S. A study of the changes in the bioactivity of essential oils used singly and as mixtures in aromatherapy. J Alternative Complement Med 1996;3(3):249-56.